JP2016516714A5 - - Google Patents

Download PDF

Info

Publication number
JP2016516714A5
JP2016516714A5 JP2016501967A JP2016501967A JP2016516714A5 JP 2016516714 A5 JP2016516714 A5 JP 2016516714A5 JP 2016501967 A JP2016501967 A JP 2016501967A JP 2016501967 A JP2016501967 A JP 2016501967A JP 2016516714 A5 JP2016516714 A5 JP 2016516714A5
Authority
JP
Japan
Prior art keywords
substituted
diyl
alkyl
independently
formula
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2016501967A
Other languages
English (en)
Japanese (ja)
Other versions
JP2016516714A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2014/025792 external-priority patent/WO2014151462A1/en
Publication of JP2016516714A publication Critical patent/JP2016516714A/ja
Publication of JP2016516714A5 publication Critical patent/JP2016516714A5/ja
Pending legal-status Critical Current

Links

JP2016501967A 2013-03-15 2014-03-13 呼吸制御調節化合物およびそれを使用する方法 Pending JP2016516714A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201361792185P 2013-03-15 2013-03-15
US61/792,185 2013-03-15
PCT/US2014/025792 WO2014151462A1 (en) 2013-03-15 2014-03-13 Novel breathing control modulating compounds, and methods of using same

Publications (2)

Publication Number Publication Date
JP2016516714A JP2016516714A (ja) 2016-06-09
JP2016516714A5 true JP2016516714A5 (enExample) 2017-04-20

Family

ID=51580966

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2016501967A Pending JP2016516714A (ja) 2013-03-15 2014-03-13 呼吸制御調節化合物およびそれを使用する方法

Country Status (14)

Country Link
US (1) US9643971B2 (enExample)
EP (1) EP2968329A4 (enExample)
JP (1) JP2016516714A (enExample)
KR (1) KR20150143498A (enExample)
CN (1) CN105209041A (enExample)
AU (1) AU2014234095A1 (enExample)
BR (1) BR112015023671A2 (enExample)
CA (1) CA2905950A1 (enExample)
EA (1) EA201591693A1 (enExample)
HK (1) HK1219234A1 (enExample)
MX (1) MX2015013137A (enExample)
SG (1) SG11201507140PA (enExample)
WO (1) WO2014151462A1 (enExample)
ZA (1) ZA201507064B (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105340281B (zh) 2013-07-05 2019-06-28 索尼公司 发送装置、发送方法、接收装置和接收方法
NO346258B1 (en) * 2015-06-30 2022-05-16 Neurad Ltd Novel breathing control modulating compounds, and methods of making and using same
US20210244742A1 (en) * 2015-07-22 2021-08-12 John Hsu Composition comprising a therapeutic agent and a respiratory stimulant and methods for the use thereof
WO2021021236A1 (en) * 2019-07-26 2021-02-04 Heteron Biotechnologies, Llc Breath analyzer and urea breath test method
KR20260053367A (ko) * 2023-08-14 2026-04-21 뉴림 파머슈티칼스(1991) 리미티드 Gal475 조성물 및 그의 사용 방법

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3031450A (en) * 1959-04-30 1962-04-24 Thomae Gmbh Dr K Substituted pyrimido-[5, 4-d]-pyrimidines
JPS557430B2 (enExample) 1972-05-17 1980-02-25
US4963541A (en) 1989-02-22 1990-10-16 Abbott Laboratories Pyrimido-pyrimidine lipoxygenase inhibiting compounds
US5075290A (en) * 1989-06-28 1991-12-24 University Of Virginia Alumni Patents Foundation Use of adenosine, adenosine analogs or nucleoside uptake blockers, e.g. dipyridamole, as drug treatments for obstructive sleep apnea and snoring
US5679650A (en) * 1993-11-24 1997-10-21 Fukunaga; Atsuo F. Pharmaceutical compositions including mixtures of an adenosine compound and a catecholamine
US6232312B1 (en) * 1995-06-07 2001-05-15 Cell Pathways, Inc. Method for treating patient having precancerous lesions with a combination of pyrimidopyrimidine derivatives and esters and amides of substituted indenyl acetic acides
DE102004002557A1 (de) * 2004-01-17 2005-08-04 Boehringer Ingelheim Pharma Gmbh & Co. Kg Verwendung von substituierten Pyrimido(5,4-d)pyrimidinen zur Behandlung von Atemwegserkrankungen
EP2061440A2 (en) * 2007-04-04 2009-05-27 Sigmoid Pharma Limited A pharmaceutical composition of tacrolimus
EP2646423A4 (en) 2010-11-29 2014-04-30 Galleon Pharmaceuticals Inc NOVEL COMPOUNDS AS RESPIRATORY STIMULANTS FOR THE TREATMENT OF RESPIRATORY DISORDERS OR DISEASES

Similar Documents

Publication Publication Date Title
CY1120705T1 (el) Καινοφανεις αναστολεις αποακετυλασων ιστονων
CY1124537T1 (el) Παραγωγο πυριδονης που εχει τετραϋδροπυρανυλ μεθυλ ομαδα
MX2015010837A (es) Compuestos de antranilamida, sus mezclas y el uso de los mismos como pesticidas.
PH12015501585A1 (en) Manufacturing process for pyrimidine derivatives
JP2012092103A5 (enExample)
JP2014526533A5 (enExample)
RU2012148909A (ru) Новый синтез соединений тиазолидиндиона
PH12016502358B1 (en) Novel pyrrolidine compound and application as melanocortin receptor agonist
MX2015012629A (es) Compuestos de imidazo piridina.
JP2016505614A5 (enExample)
MX2012013332A (es) Preparacion de intermediarios de posaconazol.
TR201905217T4 (tr) Kopanlisib ve bunun dihidroklorid tuzunun sentezi.
MX2017003238A (es) Metodo para preparar 2'-o-fucosil-lactosa.
JO3318B1 (ar) مثبطات bace
IN2014DN01629A (enExample)
CY1117688T1 (el) Ενωσεις τετραϋδροπυρρολοθειαζινης
MY183123A (en) Synthesis of copanlisib and its di hydrochloride salt
MX2018005133A (es) Intermediarios para preparar herbicidas de piridazinona y proceso para prepararlos.
MY182318A (en) Phenyl tetrahydroisoquinoline compound substituted with heteroaryl
JP2015134755A5 (enExample)
JP2016539168A5 (enExample)
MY185558A (en) Pyrido-oxazinone derivatives as tnap inhibitors
MX2015007309A (es) Derivado de hidantoina.
MX2016007985A (es) Compuestos de fluorofenilpirazol.
JP2015134710A5 (enExample)